Ready to play
Ready to play
A Chinese university is investigating the death of a girl following an experimental gene-editing trial conducted by a prominent scientist at Xinhua Hospital. The trial, funded partly by the girl’s parents, aimed to treat a rare genetic disorder but resulted in her death shortly after treatment. The incident has raised concerns about ethics, oversight, and safety in China’s rapidly expanding biotech sector, amid ongoing debates over regulation and research practices.
Notice: This Is an AI-Generated Summary
Comments (0)